ResMed Inc
(BSP:R1MD34)
R$
368.7
0.14 (0.04%)
Market Cap: 216.49 Bil
Enterprise Value: 218.91 Bil
PE Ratio: 32.69
PB Ratio: 6.97
GF Score: 87/100 
Resmed Inc at Bank of America Global Healthcare Conference (Virtual) Transcript
Sep 15, 2021 / 04:35PM GMT
Release Date Price:
R$391.16
Lyanne Harrison
BofA Securities, Research Division - VP
Hello all, and welcome. My name is Lyanne Harrison, and I'm Bank of America's health care analyst here in Australia. Today, we are fortunate to have with us Rob Douglas, Chief Operating Officer of ResMed; and David Pendarvis, Chief Administrative Officer. Hi, Rob. Hi, Dave. Thank you for taking the time to speak with us.
Robert A. Douglas
ResMed Inc. - President & COO
Hi, Lyanne, thanks for that.
David B. Pendarvis
ResMed Inc. - Chief Administrative Officer, Global General Counsel & Corporate Secretary
It's good to be here.
Robert A. Douglas
ResMed Inc. - President & COO
Yes. Lyanne...
Lyanne Harrison
BofA Securities, Research Division - VP
I wanted to tell you -- sorry, can you hear me?
Robert A. Douglas;Lyanne Harrison
ResMed Inc. - President & COO;
Yes, you go, Lyanne.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers